Archives: Speakers

Akhilesh Sharma

Dr. Akhilesh Sharma is M.D., in Clinical Pharmacology with further training in Clinical Research and Global Pharmacovigilance at Berkley Extension, California State University, USA and Luton Medical Centre, UK and is Fellow of Royal Liverpool hospital society-U.K.. He has more than 25 years of worldwide experience in areas of Clinical Research, Medical Affairs, Regulatory, Pharmacovigilance, Translation Medicine, Biomarkers, Clinical Pharmacology across various multinational pharmaceutical companies based at US & in India. He is currently President & Chief Medical Officer for Alkem Laboratories Ltd. He also co-founded biomarker research organization GeneXY in Philadelphia, USA jointly with Wistar institute, Pennsylvania university campus.

Decheng Ma

Dr. Decheng Ma is currently the Director of Global Clinical Supply at MSD R&D China.  He is responsible for managing clinical supplies for China clinical trials and external manufacturing partners in APAC area.  Decheng has been working at Merck Research Laboratories  since 2000. He has spent 7 years working in analytical chemistry, 7 years in formulation development, and 4 year in clinical supply. He has been working on numerous Merck products from preclinical to phase III, including Emend®, Isentress®, Januvia®, Janumet®, etc. Decheng has extensive experiences and built up his expertise in formulation development, analytical chemistry, and clinical supplies. He has authored over 10 peer-reviewed papers and given more than 20 presentations at pharmaceutical conferences. Decheng received his BS in polymer science & chemical engineering from Tsinghua University in China, MS in chemical engineering from Tufts University, and PhD in chemical engineering from Lehigh University in the US.

Yu Ichige

Yu Ichige
Head of Clinical Operations Japan, Korea and Taiwan
Bristol-Myers Squibb Tokyo, Japan

Yu Ichige has more than 25 years’ experience in the Pharmaceutical Industry working in the drug development space.

During his career, he has held number of positions at several global pharmaceutical companies as follows.

  • Pharmacia Clinical Operations Manager
  • Merck/Schering-Plough Regulatory Strategy Manager, Head Project Management
  • Boehringer-Ingelheim Head of Project Management

He is currently responsible for the management of clinical operations team in Japan, Korea and Taiwan.

Seung Jun Yoo

Dr. Seung Jun Yoo serves as Chief Strategy Officer at TP Global, a company of connected healthcare since December 2018.

Before moving to the current position, he worked as the Managing Director of Korea Bio-Economy Research Center at KoreaBIO (Korea Biotechnology Industry Organization) since May 2016.

He also worked for policy planning, budget allocation, and evaluation of government R&D programs, especially in life science, healthcare, and agriculture, at the Korea Institute of Science & Technology Evaluation and Planning since 2006.

He holds a Ph.D. degree in Biotechnology and Genetic Engineering from Korea University.

Hye Jung Lee

2007 – present
CEO at Caleb Multilab Inc.

2001- 2007     
CEO at Pike Inc. & Executive Director at Korea Clinical Research Center
Special Research Scientist at Seoul National Univ.

1989 – 2000
Principal Scientist at Alkermes in Boston, US &
Research Investigator in Univ. of Michgan at Ann Arbor, US.

1988
Ph.D. in Pharmaceutics at Univ of Illinois, US

1981
M.S. in Pharmacognosy at Seoul National Univ.

1979
B.S. At Ewha Womans Univ.

Chih-Ping Liu

Liu, Chih-Ping was graduated from Kaohsiung Medical College with a
bachelor degree of pharmacy in Taiwan. He was later graduated from
University of Leicester with a master degree. Liu, Chih-Ping has held
leadership roles across several different pharmaceutical industries, such
as China Chemical & Pharmaceutical Company limited, Taiwan Cynamid
Company Limited, Pfizer Inc., and Winthrop-Sterling Inc.
Liu, Chih-Ping joined TTY in 1996 and had integrated all production
lines. During his term of service, he successfully transformed the
traditional generic pharmaceutical facility into a PIC/S GMP professional
manufacturer which is dedicated in developing technology of liposome
commercial production, not only for domestic sales in Taiwan but also
to export to global markets such as Europe, USA and Asia.

Jungwon Jung

2001.09 ~ Present
CJ HealthCare
Quality Assurance & Technical development

  • 1~Present
  • Cell&Gene Therapy (Car-T) Project Team

(R&D and GMP facility construction)

  • 06~2018.12
  • New Plant Plan Project of Large Volume Parenteral

(Conceptual design with NNE from Germany)

  • TF team in strategic administration
  • 09~
  • Overseas CMO control by contact person
  • New CMO business developments and technical transfer from Japan

2000.9 ~ 2001.9
Green Cross
Quality Control

Blood and raw materials of bio product analyze.

1999.11 ~ 2000.9
LG chemical
Quality Control and Quality Assurance

Quinolone antibiotics analysis and documents control (standard operation procedure writing)

1997.02 ~ 1999.11
KATRI (Korea apparel test and research institute)

  • Analysis Lab

– Fiber content test (cotton, nylon and so on)

– AA, HPLC, GC, MS, X-RD

Michael Lee

Present
CEO of Vming Bio Company

Experience

  1. Sr. VP of Mab-Venture Bio, Shanghai.
  2. Director of GZ New Facility Project, BeiGeneBio
  3. Plant Director, JHL Bio
  4. Sr. VP, Shanghai Biomabs
  5. Director of Bio MFG Facility Projects, Merial (JV of Merck & Sanofi)
  6. VP of Shanghai Roche
  7. Technical Director of ScinoPharm
  8. Plant Director of Boehringer Ingelheim;
  9. Plant Director of GSK